OraSure Technologies EBITDA Margin 2010-2024 | OSUR
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for OraSure Technologies (OSUR) over the last 10 years. The current EBITDA margin for OraSure Technologies as of September 30, 2024 is .
| OraSure Technologies EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-09-30 | $0.22B | 0 | 0.00% |
| 2024-06-30 | $0.27B | $0.02B | 6.23% |
| 2024-03-31 | $0.30B | $0.02B | 6.91% |
| 2023-12-31 | $0.41B | $0.05B | 13.09% |
| 2023-09-30 | $0.45B | $0.07B | 14.38% |
| 2023-06-30 | $0.48B | $0.06B | 11.69% |
| 2023-03-31 | $0.47B | $0.03B | 7.17% |
| 2022-12-31 | $0.39B | $-0.01B | -1.55% |
| 2022-09-30 | $0.33B | $-0.03B | -9.45% |
| 2022-06-30 | $0.27B | $-0.05B | -17.29% |
| 2022-03-31 | $0.24B | $-0.02B | -9.84% |
| 2021-12-31 | $0.24B | $0.00B | 0.43% |
| 2021-09-30 | $0.23B | $0.02B | 7.26% |
| 2021-06-30 | $0.23B | $0.03B | 14.91% |
| 2021-03-31 | $0.20B | $0.02B | 11.56% |
| 2020-12-31 | $0.17B | $0.00B | 2.33% |
| 2020-09-30 | $0.16B | 0 | 0.00% |
| 2020-06-30 | $0.15B | $0.01B | 5.44% |
| 2020-03-31 | $0.16B | $0.02B | 14.01% |
| 2019-12-31 | $0.16B | $0.03B | 16.77% |
| 2019-09-30 | $0.16B | $0.03B | 21.29% |
| 2019-06-30 | $0.17B | $0.03B | 18.79% |
| 2019-03-31 | $0.17B | $0.03B | 18.24% |
| 2018-12-31 | $0.18B | $0.03B | 18.68% |
| 2018-09-30 | $0.18B | $0.03B | 17.93% |
| 2018-06-30 | $0.18B | $0.03B | 16.11% |
| 2018-03-31 | $0.18B | $0.03B | 17.05% |
| 2017-12-31 | $0.17B | $0.05B | 27.54% |
| 2017-09-30 | $0.15B | $0.04B | 28.67% |
| 2017-06-30 | $0.14B | $0.04B | 30.00% |
| 2017-03-31 | $0.13B | $0.04B | 30.53% |
| 2016-12-31 | $0.13B | $0.03B | 21.26% |
| 2016-09-30 | $0.12B | $0.02B | 19.35% |
| 2016-06-30 | $0.12B | $0.02B | 15.57% |
| 2016-03-31 | $0.12B | $0.02B | 14.05% |
| 2015-12-31 | $0.12B | $0.01B | 11.76% |
| 2015-09-30 | $0.12B | $0.01B | 6.03% |
| 2015-06-30 | $0.11B | $0.01B | 6.14% |
| 2015-03-31 | $0.11B | $0.01B | 6.36% |
| 2014-12-31 | $0.11B | $0.00B | 1.87% |
| 2014-09-30 | $0.11B | $0.01B | 10.28% |
| 2014-06-30 | $0.10B | $0.01B | 7.69% |
| 2014-03-31 | $0.10B | 0 | 0.00% |
| 2013-12-31 | $0.10B | $-0.01B | -5.05% |
| 2013-09-30 | $0.09B | $-0.02B | -18.48% |
| 2013-06-30 | $0.09B | $-0.02B | -20.22% |
| 2013-03-31 | $0.09B | $-0.02B | -18.18% |
| 2012-12-31 | $0.09B | $-0.01B | -10.23% |
| 2012-09-30 | $0.09B | $-0.00B | -3.33% |
| 2012-06-30 | $0.09B | $-0.01B | -5.56% |
| 2012-03-31 | $0.09B | $-0.01B | -5.81% |
| 2011-12-31 | $0.08B | $-0.01B | -6.10% |
| 2011-09-30 | $0.08B | $-0.01B | -9.09% |
| 2011-06-30 | $0.07B | $-0.00B | -4.05% |
| 2011-03-31 | $0.07B | $-0.00B | -1.35% |
| 2010-12-31 | $0.08B | $-0.00B | -1.33% |
| 2010-09-30 | $0.08B | $-0.00B | -5.19% |
| 2010-06-30 | $0.08B | $-0.00B | -3.75% |
| 2010-03-31 | $0.08B | $-0.01B | -8.97% |
| 2009-12-31 | $0.08B | $-0.01B | -7.79% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.283B | $0.405B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $194.987B | 24.87 |
| Stryker (SYK) | United States | $136.147B | 30.68 |
| Boston Scientific (BSX) | United States | $130.670B | 37.57 |
| EssilorLuxottica (ESLOY) | France | $110.026B | 0.00 |
| Medtronic (MDT) | Ireland | $102.570B | 15.24 |
| Haleon (HLN) | United Kingdom | $43.909B | 28.53 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.293B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $35.376B | 18.35 |
| ResMed (RMD) | United States | $33.995B | 27.93 |
| Terumo (TRUMY) | Japan | $28.800B | 40.67 |
| Koninklijke Philips (PHG) | Netherlands | $23.527B | 18.01 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.064B | 13.41 |
| Insulet (PODD) | United States | $17.996B | 71.67 |
| Baxter (BAX) | United States | $14.756B | 9.60 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.838B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.021B | 40.32 |
| Bio-Rad Laboratories (BIO) | United States | $9.125B | 31.01 |
| Demant (WILYY) | Denmark | $7.926B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.392B | 14.85 |
| Prestige Consumer Healthcare (PBH) | United States | $3.886B | 19.33 |
| Haemonetics (HAE) | United States | $3.862B | 18.85 |
| ICU Medical (ICUI) | United States | $3.751B | 35.71 |
| Perrigo (PRGO) | Ireland | $3.510B | 10.33 |
| Envista Holdings (NVST) | United States | $3.103B | 23.11 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.894B | 18.63 |
| GN Store Nord (GNNDY) | Denmark | $2.864B | 18.36 |
| Neogen (NEOG) | United States | $2.605B | 30.05 |
| LeMaitre Vascular (LMAT) | United States | $2.074B | 50.41 |
| Green Thumb Industries (GTBIF) | United States | $1.630B | 28.52 |
| AtriCure (ATRC) | United States | $1.465B | 0.00 |
| InMode (INMD) | Israel | $1.444B | 8.68 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.371B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.304B | 9.32 |
| BioLife Solutions (BLFS) | United States | $1.211B | 0.00 |
| Owens & Minor (OMI) | United States | $0.973B | 7.60 |
| CeriBell (CBLL) | United States | $0.958B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.955B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.883B | 15.58 |
| Evolus (EOLS) | United States | $0.688B | 0.00 |
| Omeros (OMER) | United States | $0.593B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.593B | 26.15 |
| Capricor Therapeutics (CAPR) | United States | $0.587B | 0.00 |
| Surmodics (SRDX) | United States | $0.572B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.445B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.429B | 0.00 |
| Quanterix (QTRX) | United States | $0.383B | 0.00 |
| ZimVie (ZIMV) | United States | $0.373B | 31.44 |
| Valneva SE (VALN) | France | $0.353B | 0.00 |
| Biote (BTMD) | United States | $0.313B | 6.86 |
| Viemed Healthcare (VMD) | United States | $0.312B | 29.70 |
| Canopy Growth (CGC) | Canada | $0.295B | 0.00 |
| Cerus (CERS) | United States | $0.293B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.276B | 0.00 |
| Zynex (ZYXI) | United States | $0.268B | 56.00 |
| High Tide (HITI) | Canada | $0.237B | 98.00 |
| Aurora Cannabis (ACB) | Canada | $0.225B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.211B | 14.54 |
| MacroGenics (MGNX) | United States | $0.200B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.188B | 2.64 |
| Organigram Holdings (OGI) | Canada | $0.184B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.181B | 0.00 |
| Brainsway (BWAY) | Israel | $0.169B | 89.60 |
| FitLife Brands (FTLF) | United States | $0.151B | 19.04 |
| Jin Medical (ZJYL) | China | $0.132B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.110B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.104B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 10.79 |
| Veru (VERU) | United States | $0.092B | 0.00 |
| Exagen (XGN) | United States | $0.083B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.066B | 34.17 |
| InterCure (INCR) | Israel | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Modular Medical (MODD) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.82 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |